References
- Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007; 184:37–44.
- Zhu B, Luo L, Moore GRW, Paty DW, Cynader MS. Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol. 2003; 162:1639–1650.
- Ludwin SK. The pathogenesis of multiple sclerosis: Relating human pathology to experimental studies. J Neuropathol Exp Neurol. 2006; 65:205–318.
- McFarland HF, Martin R. Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol. 2007; 8:913–919.
- Vilcaes AA, Furlan G, Roth GA. Inhibition of Ca2+-dependent glutamate release in cerebral cortex synaptosomes of rats with experimental autoimmune encephalomyelitis. J Neurochem. 2009; 108:881–890.
- Pedraza LT, Roth GA, Cumar FA. Identification as synapsin of a synaptosomal protein immunoreacting with anti-myelin basic protein antiserum. J Neurochem. 1988; 51:413–420.
- De Santis ML, Roth GA, Cumar FA. Cellular immune crossreactivity between myelin basic protein and synapsin in rats with experimental allergic encephalomyelitis. J Neurosci Res. 1992; 31:46–51.
- De Santis ML, Roth GA. Experimental allergic encephalomyelitis: Characterization of T lymphocytes that bind myelin basic protein and synapsin. J Neurosci Res. 1996; 43:50–54.
- Slavin DA, Bucher AE, Degano AL, Soria NW, Roth GA. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis. Neurochem Int. 1996; 29:597–605.
- Hirshfeld H, Teitelbaum D, Arnon R, Sela M. Basic encephalitogenic protein: A simplified purification on sulphoethyl-sephadex. FEBS Lett. 1970; 7:317–320.
- Schiebler W, Jahn R, Doucet JP, Rothlein J, Greengard P. Characterization of synapsin I binding to small synaptic vesicles. J Biol Chem. 1986; 261:8383–8390.
- Smith DB, Corcoran LM. Current protocols in molecular biology. New York, NY: Wiley.1990.
- Teitelbaum D, Arnon R, Sela M. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer I. Proc Natl Acad Sci USA. 1999; 96:3842–3847.
- Aharoni R, Teitelbaum D, Sela M, Arnon T. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 1991; 94:10821–10826.
- Degano AL, Bucher AE, Roth GA. Suppression of acute experimental allergic encephalomyelitis by intraperitoneal administration of synaptosomal antigens. J Neurosci Res. 1998; 53:187–194.
- Polak T, Schlaf G, Schöll U, Krome-Cesar C, Mäder M, Felgenhauer K, Weber F. Characterization of the human T cell response against the neuronal protein synapsin in patients with multiple sclerosis. J Neuroimmunol. 2001; 115:176–181.
- Degano AL, Ditamo Y, Roth GA. Neuronal antigens modulate the immune response associated to Experimental autoimmune encephalomyelitis (EAE). Immunol Cell Biol. 2004; 82:17–23.
- Scerbo MJ, Rupil LL, Bibolini MJ, Roth GA, Monferran CG. Neuroprotective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. J Neurosci Res. 2009; 87:2273–2281.